Hexyl aminolevulinate, 5‐aminolevulinic acid nanoemulsion, and methyl aminolevulinate in photodynamic therapy of non‐aggressive basal cell carcinomas : A non‐sponsored, randomized, prospective and double‐blinded trial
Salmivuori, M., Grönroos, M., Tani, T., Pölönen, I., Räsänen, J., Annala, L., Snellman, E., & Neittaanmäki, N. (2020). Hexyl aminolevulinate, 5‐aminolevulinic acid nanoemulsion, and methyl aminolevulinate in photodynamic therapy of non‐aggressive basal cell carcinomas : A non‐sponsored, randomized, prospective and double‐blinded trial. Journal of the European Academy of Dermatology and Venereology, 34(12), 2781-2788. https://doi.org/10.1111/jdv.16357
Julkaistu sarjassa
Journal of the European Academy of Dermatology and VenereologyTekijät
Tani, T. |
Päivämäärä
2020Tekijänoikeudet
© 2020 Wiley-Blackwell
Background
In the photodynamic therapy (PDT) of non‐aggressive basal cell carcinomas (BCCs), 5‐aminolevulinic acid nanoemulsion (BF‐200ALA) has shown non‐inferior efficacy when compared with methyl aminolevulinate (MAL), a widely used photosensitizer. Hexyl aminolevulinate (HAL) is an interesting alternative photosensitizer. To our knowledge, this is the first study using HAL‐PDT in the treatment of BCCs.
Objectives
To compare the histological clearance, tolerability (pain and post‐treatment reaction), and cosmetic outcome of MAL, BF‐200 ALA, and low‐concentration HAL in the PDT of non‐aggressive BCCs.
Methods
Ninety‐eight histologically verified non‐aggressive BCCs met the inclusion criteria, and 54 patients with 95 lesions completed the study. The lesions were randomized to receive LED‐PDT in two repeated treatments with MAL, BF‐200 ALA, or HAL. Efficacy was assessed both clinically and confirmed histologically at three months by blinded observers. Furthermore, cosmetic outcome, pain, post‐treatment reactions fluorescence, and photobleaching were evaluated.
Results
According to intention‐to‐treat analyses, the histologically confirmed lesion clearance was 93.8% (95% confidence interval [CI] = 79.9–98.3) for MAL, 90.9% (95% CI = 76.4–96.9) for BF‐200 ALA, and 87.9% (95% CI = 72.7–95.2) for HAL, with no differences between the arms (p=0.84). There were no differences between the arms as regards pain, post‐treatment reactions, or cosmetic outcome.
Conclusions
PDT with low‐concentration HAL and BF‐200 ALA have a similar efficacy, tolerability, and cosmetic outcome compared to MAL. HAL is an interesting new option in dermatological PDT, since good efficacy is achieved with a low concentration.
...
Julkaisija
Wiley-BlackwellISSN Hae Julkaisufoorumista
0926-9959Asiasanat
Julkaisu tutkimustietojärjestelmässä
https://converis.jyu.fi/converis/portal/detail/Publication/35099625
Metadata
Näytä kaikki kuvailutiedotKokoelmat
Lisätietoja rahoituksesta
This clinical trial has been funded by research grants from the Finnish Dermatological Society, the Cancer Foundation Finland, the Foundation for Clinical Chemistry Research, the Instrumentarium Science Foundation, Tampere University, and the Competitive Research Financing of the Expert Responsibility Area of Tampere University Hospital.Lisenssi
Samankaltainen aineisto
Näytetään aineistoja, joilla on samankaltainen nimeke tai asiasanat.
-
Ablative fractional laser‐assisted photodynamic therapy for lentigo maligna : a prospective pilot study
Räsänen, J.E.; Neittaanmäki, N.; Jeskanen, L.; Pölönen, I.; Snellman, E.; Grönroos, M. (Wiley-Blackwell Publishing Ltd., 2020)Background Lentigo maligna (LM) is an in‐situ form of melanoma carrying a risk of progression to invasive lentigo maligna melanoma (LMM). LM poses a clinical challenge, with subclinical extension and high recurrence rates ... -
Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules
Barakat, Assem; Alshahrani, Saeed; Al-Majid, Abdullah Mohammed; Alamary, Abdullah Saleh; Haukka, Matti; Abu-Serie, Marwa, M.; Dömling, Alexander; Domingo, Luis, R.; Elshaier, Yaseen A. M. M. (Frontiers Media SA, 2024)This study discusses the synthesis and use of a new library of spirooxindole-benzimidazole compounds as inhibitors of the signal transducer and activator of p53, a protein involved in regulating cell growth and cancer ... -
The prognostic role of tumor budding and tumor-stroma ratio in pulmonary metastasis of colorectal carcinoma
Karjula, Topias; Kemi, Niko; Niskakangas, Anne; Mustonen, Olli; Puro, Iiris; Pohjanen, Vesa-Matti; Kuopio, Teijo; Elomaa, Hanna; Ahtiainen, Maarit; Mecklin, Jukka-Pekka; Seppälä, Toni T.; Wirta, Erkki-Ville; Sihvo, Eero; Väyrynen, Juha P.; Yannopoulos, Fredrik; Helminen, Olli (Elsevier, 2023)Objective To evaluate the prognostic value of tumor budding and tumor-stroma ratio (TSR) in resected pulmonary metastases of colorectal carcinoma (CRC). Methods In total, 106 pulmonary metastasectomies were performed ... -
Discriminating Basal Cell Carcinoma and Bowen’s Disease with Novel Hyperspectral Imaging System and Convolutional Neural Networks
Salmivuori, Mari; Lindholm, Vivian; Annala, Leevi; Raita-Hakola, Anna-Maria; Jeskanen, Leila; Pölönen, Ilkka; Koskenmies, Sari; Pitkänen, Sari; Isoherranen, Kirsi; Ranki, Annamari (Society for Publication of Acta Dermato-Venereologica, 2022) -
Decorin Expression and Oncosuppression in Human Embryonic Carcinomas
Sainio, Annele; Pennanen, Mirka; Laine, Jukka; Lund, Riikka; Söderström, Mirva; Kuopio, Teijo; Järveläinen, Hannu (Fortune Journals, 2019)Human embryonic stem cells in culture can transform into malignant, cancer-like cells exhibiting lesser differentiation. After transplantation, these transformed cells can form highly malignant germ cell tumors. In humans, ...
Ellei toisin mainittu, julkisesti saatavilla olevia JYX-metatietoja (poislukien tiivistelmät) saa vapaasti uudelleenkäyttää CC0-lisenssillä.